28 Deli, Cheese, and Antipasti Suppliers Join ReposiTrak Traceability Network for Compliance with Wholesale Customers' Requirements
ByAinvest
Wednesday, Aug 27, 2025 7:04 am ET1min read
TRAK--
The new suppliers will exchange intricate FDA-required data through ReposiTrak's platform, which requires no additional hardware and offers an error detection process to ensure data accuracy. This solution is designed to help retailers, suppliers, food manufacturers, and wholesalers maintain compliance with regulatory requirements.
The expansion of ReposiTrak's network underscores the increasing importance of traceability in the food supply chain. As pharmaceutical distributors prepare for the DSCSA deadline, similar efforts are being made in the food industry to ensure the safety and integrity of products [1].
ReposiTrak's solution is supported by a team of experts who provide ongoing support and guidance to ensure compliance. This robust network is designed to help businesses navigate the complexities of data management and regulatory requirements, ultimately enhancing patient safety and building trust in the healthcare system [2].
References:
[1] https://www.tecsys.com/blog/crunch-time-3-dscsa-takeaways-from-hda-2025-traceability-seminar
[2] https://www.tecsys.com/blog/crunch-time-3-dscsa-takeaways-from-hda-2025-traceability-seminar
ReposiTrak has added 28 deli, cheese, and antipasti suppliers to its traceability network, meeting the growing demands of their retail customers. The companies will exchange intricate FDA-required data with the goal of meeting traceability requirements by 2025. ReposiTrak's solution requires no additional hardware and provides an error detection process to ensure data accuracy. The network is supported by a team of experts and provides a robust solution for retailers, suppliers, food manufacturers, and wholesalers to remain in compliance with regulatory requirements.
ReposiTrak, a leading traceability solution provider, has announced the addition of 28 new suppliers to its network, focusing on deli, cheese, and antipasti products. This move aims to address the growing demand for traceability in the retail sector, aligning with the Drug Supply Chain Security Act (DSCSA) compliance deadline of 2025.The new suppliers will exchange intricate FDA-required data through ReposiTrak's platform, which requires no additional hardware and offers an error detection process to ensure data accuracy. This solution is designed to help retailers, suppliers, food manufacturers, and wholesalers maintain compliance with regulatory requirements.
The expansion of ReposiTrak's network underscores the increasing importance of traceability in the food supply chain. As pharmaceutical distributors prepare for the DSCSA deadline, similar efforts are being made in the food industry to ensure the safety and integrity of products [1].
ReposiTrak's solution is supported by a team of experts who provide ongoing support and guidance to ensure compliance. This robust network is designed to help businesses navigate the complexities of data management and regulatory requirements, ultimately enhancing patient safety and building trust in the healthcare system [2].
References:
[1] https://www.tecsys.com/blog/crunch-time-3-dscsa-takeaways-from-hda-2025-traceability-seminar
[2] https://www.tecsys.com/blog/crunch-time-3-dscsa-takeaways-from-hda-2025-traceability-seminar
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet